A detailed history of Great West Life Assurance CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 2,027,614 shares of ABBV stock, worth $345 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
2,027,614
Previous 1,987,865 2.0%
Holding current value
$345 Million
Previous $341 Million 17.57%
% of portfolio
0.7%
Previous 0.64%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $6.51 Million - $7.92 Million
39,749 Added 2.0%
2,027,614 $401 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $17.4 Million - $20.3 Million
112,206 Added 5.98%
1,987,865 $341 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $1.6 Million - $1.83 Million
10,036 Added 0.54%
1,875,659 $341 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $56 Million - $63.1 Million
407,116 Added 27.91%
1,865,623 $288 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $4.57 Million - $5.29 Million
34,176 Added 2.4%
1,458,507 $217 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $3.21 Million - $3.99 Million
-24,205 Reduced 1.67%
1,424,331 $193 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $8.58 Million - $9.88 Million
59,300 Added 4.27%
1,448,536 $231 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $14.7 Million - $17.6 Million
-105,936 Reduced 7.09%
1,389,236 $226 Million
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $201 Million - $230 Million
1,495,172 New
1,495,172 $201 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $3.02 Million - $3.84 Million
-21,961 Reduced 1.44%
1,499,811 $230 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $1.45 Million - $1.8 Million
10,980 Added 0.73%
1,521,772 $260 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $1.27 Million - $1.6 Million
-11,800 Reduced 0.77%
1,510,792 $204 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $1.35 Million - $1.54 Million
-12,733 Reduced 0.83%
1,522,592 $165 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $3.65 Million - $4.06 Million
34,657 Added 2.31%
1,535,325 $173 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $40.9 Million - $45 Million
-399,859 Reduced 21.04%
1,500,668 $161 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $1.23 Million - $1.66 Million
15,287 Added 0.81%
1,900,527 $203 Million
Q3 2020

Nov 17, 2020

SELL
$85.91 - $100.83 $963,051 - $1.13 Million
-11,210 Reduced 0.59%
1,885,240 $165 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $5.69 Million - $6.68 Million
66,269 Added 3.62%
1,896,450 $166 Million
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $26.2 Million - $35 Million
356,830 Added 24.22%
1,830,181 $179 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $14 Million - $21.3 Million
217,542 Added 17.32%
1,473,351 $113 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $1.51 Million - $1.89 Million
-20,910 Reduced 1.64%
1,255,809 $111 Million
Q3 2019

Oct 25, 2019

SELL
$62.98 - $75.72 $13.1 Million - $15.7 Million
-207,736 Reduced 13.99%
1,276,719 $96.7 Million
Q2 2019

Jul 31, 2019

BUY
$65.7 - $83.98 $7.12 Million - $9.1 Million
108,330 Added 7.87%
1,484,455 $0
Q1 2019

May 08, 2019

BUY
$77.14 - $90.79 $12.4 Million - $14.6 Million
161,240 Added 13.27%
1,376,125 $111 Million
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $9.65 Million - $11.9 Million
-123,942 Reduced 9.26%
1,214,885 $107 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $10.5 Million - $11.7 Million
-118,558 Reduced 8.13%
1,338,827 $127 Million
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $5.96 Million - $7.06 Million
66,436 Added 4.78%
1,457,385 $135 Million
Q1 2018

May 10, 2018

SELL
$92.01 - $123.21 $6.31 Million - $8.45 Million
-68,589 Reduced 4.7%
1,390,949 $132 Million
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $3.49 Million - $3.83 Million
38,963 Added 2.74%
1,459,538 $141 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $99.2 Million - $127 Million
1,420,575
1,420,575 $126 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.